In 2018, a study of 737 G6PD-d individuals in the US Armed Forces demonstrated a covariate-adjusted risk of ASCVD that was 39.6% higher than non-deficient controls 18
Table 1: Semax potential areas of benefit and research status These potential benefits are based on published research and do not constitute medical claims
Signs the protocol may need adjustment If no improvements in sleep quality, energy, or subjective well-being occur after completing a full cycle, researchers might consider whether reconstitution was performed correctly, whether the peptide source is legitimate, or whether administration technique is adequate
The decreased effect of exendin-4 is not specific to the NOD mouse colony at the Department of Pathology, as this was also observed in other NOD mouse colonies (Supplementary figure 1a, 1b), and the effect does not appear to be dominant, as F1 offspring of a C57BL/6xNOD cross do exhibit a response to injection of exendin-4 (Fig